| Identification | Back Directory | [Name]
FMOC-HIS(MTT)-OH | [CAS]
133367-34-7 | [Synonyms]
FMOC-HIS(MTT)-OH
FMOC-L-HIS(MTT)-OH
Fmoc-His(1-Mtt)-OH
FMoc-His(t-Mtt)-OH
Fmoc-His(tau-Mtt)-OH
FMOC-HISTIDINE(MTT)-OH
FMOC-N-IM-METHYLTRITYL-L-HISTIDINE
Nα-Fmoc-Nim-methyltrityl-L-histidine
N(ALPHA)-FMOC-N(IM)-(4-METHYLTRITYL)-
N-ALPHA-FMOC-N-IM-METHYLTRITYL-L-HISTIDINE
nα-fmoc-n(im)-(4-methyltrityl)-l-histidine
(9H-Fluoren-9-yl)MethOxy]Carbonyl His(Mtt)-OH
N-ALPHA-FMOC-N(IM)-(4-METHYLTRITYL)-L-HISTIDINE
Nα-Fmoc-Nim-methyltrityl-L-histidine≥ 99% (HPLC)
NALPHA-9-Fluorenylmethoxycarbonyl-NOMEGA-methyltrityl-L -histidine
N-ALPHA-(9-FLUORENYLMETHOXYCARBONYL)-N-TAU-METHYLTRITYL-L-HISTIDINE
N-ALPHA-(9-FLUORENYLMETHYLOXYCARBONYL)-N-IM-P-METHYLTRITYL-L-HISTIDINE
N-ALPHA-(9-FLUOROENYLMETHYLOXYCARBONYL)-N-IM-P-METHYLTRITYL-L-HISTIDINE
L-Histidine, N-[(9H-fluoren-9-ylmethoxy)carbonyl]-1-[(4-methylphenyl)diphenylmethyl]-
(2S)-2-(9H-fluoren-9-ylmethoxycarbonylamino)-3-[1-[(4-methylphenyl)-diphenylmethyl]imidazol-4-yl]propanoic acid
(2S)-2-({[(9H-fluoren-9-yl)methoxy]carbonyl}amino)-3-{1-[(4-methylphenyl)diphenylmethyl]-1H-imidazol-4-yl}propanoic acid | [Molecular Formula]
C41H35N3O4 | [MDL Number]
MFCD00153358 | [MOL File]
133367-34-7.mol | [Molecular Weight]
633.73 |
| Chemical Properties | Back Directory | [Boiling point ]
820.0±65.0 °C(Predicted) | [density ]
1.23±0.1 g/cm3(Predicted) | [storage temp. ]
2-8°C | [form ]
powder | [pka]
3.03±0.10(Predicted) | [Appearance]
White to off-white Solid | [Major Application]
peptide synthesis | [InChIKey]
MNOCIIYDYLYWEU-LHEWISCISA-N | [SMILES]
C(O)(=O)[C@H](CC1N=CN(C(C2=CC=C(C)C=C2)(C2=CC=CC=C2)C2=CC=CC=C2)C=1)NC(OCC1C2=C(C=CC=C2)C2=C1C=CC=C2)=O |
| Hazard Information | Back Directory | [Chemical Properties]
White crystals | [Uses]
peptide synthesis | [reaction suitability]
reaction type: Fmoc solid-phase peptide synthesis |
|
|